BCR and acute promyelocytic leukemia: Due to the limited number of available studies in the Middle East region, including Iran, as well as the small sample size of APL patients in these few studies, the demographic characteristics, clinical manifestations, distribution of bcr isoforms, and prognostic factors influencing overall survival rates remain unclear.